Metalloproteases
Metalloproteases - Related Videos
01:23
Role of Matrix Metalloproteases in Degradation of ECM
0 Views •
2023
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body. A...
06:46
Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
0 Views •
Cited by 4 •
2017
This paper explains the application of fluorescent imaging using an activatable optical imaging probe to visualize the in vivo activity of key matrix metalloproteinases in two different experimental models of inflammation.
07:58
Invasion Assay Using 3D Matrices
0 Views •
2023
The extracellular matrix (ECM) is a network of molecules that provide a structural framework for cells and tissues and helps facilitate intercellular communication. Three-dimensional cell culture techniques have been developed to more accurately model this extracellular environment for in vitro study. While many cell processes during migration through 3D matrices are similar to those required for movement across rigid 2D surfaces, including adherence, migration through ECM also requires cells...
FAQs
Catalytic chemistry alone does not determine which proteins are cleaved. Substrate-recognition domains help direct a metalloprotease toward particular targets, while activation mechanisms regulate when the enzyme becomes capable of proteolysis. Together, these features provide spatial and temporal control, allowing protein cleavage to influence extracellular or intracellular processes in specific biological settings.
The bound metal ion, commonly zinc, supports the catalytic site as it positions water for peptide-bond hydrolysis. This arrangement enables the enzyme to cleave target proteins rather than merely bind them. Changes in substrate recognition or activation can still determine the biological result, because catalytic capacity must be matched with access to an appropriate protein target.
Proteolysis can remodel the extracellular matrix, the structural protein network surrounding cells, and can also release growth factors from their associated environments. These changes may affect tumor-cell invasion and angiogenesis, the formation of new blood vessels. Consequently, metalloprotease activity can influence how tumor cells interact with surrounding tissue and acquire conditions that support progression.
Researchers measure metalloprotease activity to examine whether proteolysis is associated with disease-related changes. Activity measurements can contribute to identifying disease-associated biomarkers, which are measurable features linked to disease state. This approach adds functional information beyond simply noting that a metalloprotease is present, helping investigators evaluate its potential relevance to cancer-associated tissue remodeling.
Selective inhibitors are intended to limit pathological tissue remodeling while preserving metalloprotease functions needed for normal physiology. This distinction matters because broad disruption of proteolysis could interfere with essential processes. In cancer research, inhibitor strategies therefore focus not only on reducing enzymatic activity, but also on achieving sufficient selectivity to avoid unwanted effects on physiological protein regulation.
Metalloprotease research in cancer commonly examines extracellular matrix remodeling, growth-factor release, tumor-cell invasion, angiogenesis, and metastasis. These areas connect enzymatic activity with changes in tissue structure, signaling environments, blood-vessel development, and tumor dissemination. Studying the links among these outcomes can support biomarker discovery and the evaluation of selective therapeutic strategies.